# Study of Transcranial Direct Current Stimulation to Treat Epilepsy

> **NCT05673915** · NA · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 30 (estimated)

## Conditions studied

- Focal Epilepsy
- Generalized Onset Epilepsy
- Sleep-related Epileptic Encephalopathy

## Interventions

- **DEVICE:** ActivaDose II 0.1 mA transcranial direct current stimulation (tDCS)
- **DEVICE:** ActivaDose II 2.0 mA transcranial direct current stimulation (tDCS)

## Key facts

- **NCT ID:** NCT05673915
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-12
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05673915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05673915, "Study of Transcranial Direct Current Stimulation to Treat Epilepsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05673915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*